NVYTF

Healthcare Medical Devices

Novacyt S.A.

$0.57

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

41.40M

Avg Volume

EPS

-$0.42

52W High

$0.57

52W Low

$0.48

Div. Yield

0.0%

Valuation

P/B Ratio

1.27

P/S Ratio

1.90

EV/EBITDA

13.39

EV/Revenue

1.94

Margins

Gross Margin 52.5%

Operating Margin (42.3%)

Net Margin (102.5%)

EBITDA Margin 14.5%

Growth & Returns

Revenue Growth (YoY)

18.0%

Return on Equity

(75.2%)

Return on Assets

(13.6%)

Liquidity & Leverage

Current Ratio

3.14

Quick Ratio

2.19

Debt / Equity

0.55

Total Cash

8.93M

Total Debt

10.25M

About

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.